The perpetrator potential of sitaxentan based on its ability to inhibit human cytochrome P450 (CYP) enzymes Source: Annual Congress 2008 - Pulmonary vascular disease and other pulmonary conditions: miscellaneous Year: 2008
Expression of xenobiotic-metabolizing enzymes in human pulmonary tissue: possible role in susceptibility for ILD Source: Eur Respir J 2001; 18: 122S-126S Year: 2001
Interactions between roflumilast and cytochrome P450 inducers and inhibitors: Overview of existing studies Source: Annual Congress 2010 - Management of airway disease Year: 2010
Effects of aryl hydrocarbon receptor and cytochrome P450 1A1 polymorphisms on childhood lung function and asthma Source: Eur Respir J 2007; 30: Suppl. 51, 296s Year: 2007
The perpetrator potential of sitaxentan: human CYP enzyme induction Source: Annual Congress 2008 - Pulmonary vascular disease and other pulmonary conditions: miscellaneous Year: 2008
The victim potential of sitaxentan: metabolism by human CYP450 enzymes Source: Annual Congress 2008 - Pulmonary vascular disease and other pulmonary conditions: miscellaneous Year: 2008
Cytochrome P450 pharmacogenetics: a possible predictor of pulmonary drug induced toxicity? Source: Eur Respir J 2007; 30: Suppl. 51, 488s Year: 2007
Comparison of inhibitory potentials of pranlukast and zafirlukast on human liver CYP isoforms Source: Eur Respir J 2003; 22: Suppl. 45, 102s Year: 2003
Epoxyeicosatrienoates are the dominant eicosanoids in human lungs upon microbial challenge Source: Eur Respir J 2010; 36: 1088-1098 Year: 2010
Association analysis between polymorphisms in the cytochrome P450 2J2, 2S1 and UDP-glucuronosyltransferase 2B7 genes with occupational chronic bronchitis Source: Annual Congress 2010 - Genetics of obstruction Year: 2010
Diamine oxidase activation by diphenhydramine – in vitro but no in vivo effect Source: Eur Respir J 2003; 22: Suppl. 45, 110s Year: 2003
Cytochrome P450 2A5 methylation and gene expression profile is organ-specific and affected by maternal smoking during pregnancy Source: International Congress 2018 – Functional genomics and COPD: new challenges Year: 2018
Cytochrome P450 1A1 polymorphism and severity of COPD Source: Eur Respir J 2002; 20: Suppl. 38, 212s Year: 2002
Genetic polymorphisms in the cytochromes P450, microsomal epoxide hydrolase and glutathione S-transferase M1, T1 and P1 genes and their relationship to relapsing bronchitis and pneumonia in case of children Source: Eur Respir J 2005; 26: Suppl. 49, 167s Year: 2005
Reversible inhibition of mitochondrial complex IV activity in PBMC following acute smoking Source: Eur Respir J 2004; 23: 214-218 Year: 2004
Novel inhibitory effect on 5-lipoxygenase activity by montelukast. Evidence for a noncompetitive mode of action Source: Eur Respir J 2004; 24: Suppl. 48, 96s Year: 2004
The uptake of ciclesonide-active metabolite and budesonide into human hepatocytes in vitro – the effect of serum protein binding Source: Eur Respir J 2006; 28: Suppl. 50, 434s Year: 2006
Effects of zileuton on leukotriene formation in human blood cells and expression of enzymes in the biosynthetic pathway Source: Eur Respir J 2006; 28: Suppl. 50, 316s Year: 2006
Interaction of GSTMI null variant and cytochrome P-450 type 1A1 Ile462Val polymorphism and susceptibility to COPD Source: Eur Respir J 2002; 20: Suppl. 38, 94s Year: 2002
The effect of antioxidant tetrapeptide UPF1 on enzymes involved in glutathione metabolism in human bronchial epithelial cells exposed to oxidative stress Source: Annual Congress 2010 - Novel insights into the pathophysiology of asthma and COPD Year: 2010